<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: EBV and other herpesviruses are associated with a variety of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The EBV <z:chebi fb="0" ids="17748">thymidine</z:chebi> kinase (TK) is either not expressed or is expressed at very low levels in EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>However, EBV-TK expression can be induced in vitro with several chemotherapeutic agents that promote <z:mp ids='MP_0001799'>viral</z:mp> lytic induction </plain></SENT>
<SENT sid="3" pm="."><plain>The goal of this study is to image EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> by induction of <z:mp ids='MP_0001799'>viral</z:mp> TK expression with radiolabeled 2'-fluoro-2'-deoxy-beta-D-5-iodouracil-arabinofuranoside (FIAU) </plain></SENT>
<SENT sid="4" pm="."><plain>EXPERIMENTAL DESIGN: Immunoblot, luciferase reporter assay, and in vitro assay with [(14)C]FIAU were used to show the effects of <z:chebi fb="0" ids="52717">bortezomib</z:chebi> on the induction of lytic gene expression of EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>In vivo imaging and ex vivo biodistribution studies with [(125)I]FIAU on EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were done to visualize and confirm, respectively, the EBV(+) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific effects of <z:chebi fb="0" ids="52717">bortezomib</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In vitro assays with [(14)C]FIAU and ex vivo biodistribution studies with [(125)I]FIAU showed that uptake and retention of radiolabeled FIAU was specific for cells that express EBV-TK </plain></SENT>
<SENT sid="7" pm="."><plain>Planar gamma imaging of EBV(+) Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> xenografts in severe combined immunodeficient mice showed [(125)I]FIAU localization within <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> following treatment with <z:chebi fb="0" ids="52717">bortezomib</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: These results indicate the feasibility of imaging chemotherapy-mediated <z:mp ids='MP_0001799'>viral</z:mp> lytic induction by radiopharmaceutical-based techniques such as single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography and <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography </plain></SENT>
</text></document>